Many of the deadliest cancers receive the least amount of research fundingAllbiopro2019-07-24T11:41:45+09:007월 24th, 2019|
FDA Approves MED-EL USA’s Cochlear Implants for Single-Sided Deafness and Asymmetric Hearing LossAllbiopro2019-07-23T11:26:39+09:007월 23rd, 2019|
DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational ProductAllbiopro2019-07-23T11:25:45+09:007월 23rd, 2019|
The Trendlines Group Receives SGD10.88 Million (USD8 million) InvestmentAllbiopro2019-07-23T11:24:51+09:007월 23rd, 2019|
Velan Announces Progenics Pharmaceuticals Stockholders Support its Campaign for Change at Progenics’ 2019 Annual MeetingAllbiopro2019-07-23T11:23:57+09:007월 23rd, 2019|
Ocuphire Pharma Raises Over $5 Million to Complete Multiple Late Phase 2 Clinical TrialsAllbiopro2019-07-23T11:23:02+09:007월 23rd, 2019|
Alz1 Launches the First At-Home Solution to Detect, Help Reduce Risk Factor Associated with Alzheimer’s DiseaseAllbiopro2019-07-23T11:22:08+09:007월 23rd, 2019|
IQVIA Named to Forbes 2019 List of America’s Best Employers for WomenAllbiopro2019-07-23T11:21:12+09:007월 23rd, 2019|
SHINE Files Application With Federal Regulators to Produce Medical Isotopes in Short SupplyAllbiopro2019-07-23T11:20:19+09:007월 23rd, 2019|
Vertex Submits New Drug Application to the U.S. FDA for Triple Combination Regimen of VX-445 (Elexacaftor), Tezacaftor and Ivacaftor in Cystic FibrosisAllbiopro2019-07-23T11:19:25+09:007월 23rd, 2019|
IMFINZI® (durvalumab) US Label Updated With Overall Survival Data in Unresectable, Stage III Non-small Cell Lung CancerAllbiopro2019-07-23T11:18:27+09:007월 23rd, 2019|
Subcutaneous Formulation of Takeda’s Entyvio Hits the Mark in Crohn’s TrialAllbiopro2019-07-23T11:17:30+09:007월 23rd, 2019|
FDA Approves First Treatment for Oral Ulcers Associated with Rare Inflammatory DiseaseAllbiopro2019-07-23T11:16:32+09:007월 23rd, 2019|
Baxter International Nabs FDA Approval for Insulin IV InfusionAllbiopro2019-07-23T11:15:37+09:007월 23rd, 2019|
Link Between Diabetes and Arterial Restriction Could Lead to New TreatmentsAllbiopro2019-07-23T11:14:39+09:007월 23rd, 2019|
InvaGen Receives FDA Approval for Generic of Pfizer’s LyricaAllbiopro2019-07-23T11:12:50+09:007월 23rd, 2019|
